SkinVision
About SkinVision
SkinVision is a health technology company that leverages artificial intelligence (AI) to provide a clinically validated solution for the early recognition and tracking of common forms of skin cancer, including melanoma, basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and precancerous actinic keratosis. The mobile application allows individuals to take photos of their skin lesions, which are then analyzed by a proprietary algorithm to provide an immediate risk indication (low, low with symptoms, or high risk) and recommendations for next steps, including whether to seek professional medical advice.
For physicians, SkinVision serves as a valuable digital triage and monitoring tool, aiming to support the current healthcare system by directing appropriate patients to dermatologists while potentially reducing unnecessary referrals. Clinical studies have demonstrated the app’s high sensitivity, with recent validations showing levels around 90% for detecting the three most common forms of skin cancer, and a reported sensitivity of 95% in some studies, which is often cited as being higher than that of general practitioners and even some dermatologists. The platform also facilitates patient engagement by enabling them to track changes in their skin over time and share a personal archive of images with their healthcare providers, thereby improving efficiency and aiding in timely diagnosis and treatment.
SkinVision is a CE-marked medical device (EU MDR Class IIa) and is ISO certified for information security and medical device quality management, underscoring its commitment to regulatory compliance and data security. The company actively collaborates with medical experts, researchers, and institutions, and partners with health insurers and healthcare organizations to integrate its technology into broader preventive care platforms.
Focus Areas
Business Intelligence
| Key Investors | LEO Pharma, PHS Capital, Rubio VC, Personal Health Solutions, LEO Innovation Lab |
| Partnerships | Mayo Clinic (research collaboration), Benenden Health, UniMed, CZ, Just, Nationale-Nederlanden, Generali (Central), Medicash, Health Shield, BHSF, Accuro |
| Technology | AI-powered algorithms, machine learning (Convolutional Neural Networks, Support Vector Machines), image processing (edge detection, segmentation), fractal geometry, mobile application (iOS/Android), cloud-native |
What Physicians Need to Know
For physicians, it's crucial to understand that SkinVision is a *screening tool* providing a *risk indication*, not a definitive diagnosis. Encourage patients to use it for consistent self-monitoring and to bring their saved images and risk assessments to appointments for a more informed consultation. This tool can significantly aid in prioritizing patients and improving the efficiency of dermatological referrals by identifying potentially high-risk lesions early. It serves as a valuable adjunct to traditional clinical examination, not a replacement.
SkinVision has established partnerships with numerous health insurance providers globally, enabling reimbursement and broader access for millions of users. The company also collaborates with academic institutions and dermatologists for ongoing clinical validation and algorithm refinement. While direct Electronic Medical Record (EMR) integrations (e.g., Epic, Cerner) are noted as a slower development in the broader dermatology tech landscape, SkinVision's B2B2C model with insurers and its focus on improving referral pathways suggest potential for future system-level integrations.
What the Web Says
SkinVision is an app that uses artificial intelligence and, in some cases, dermatologists, to assess the risk of skin lesions and moles for skin cancer. It aims to help users monitor their skin and provide an early warning system, though it explicitly states it is not a diagnostic tool and does not replace professional medical advice. The app has received mixed reviews regarding its accuracy and pricing model, but many users appreciate its role in prompting timely dermatologist visits.
Overall: MixedStrengths
- Easy to use and user-friendly interface.
- Provides quick risk assessments for skin lesions.
- Helps users monitor changes in moles over time and set reminders.
- Can prompt users to seek professional medical attention, leading to early diagnosis.
- Backed by research and clinically tested, with reported high sensitivity in some studies.
- Offers peace of mind for users concerned about skin spots.
Limitations
- Not a diagnostic tool and does not replace a dermatologist's visit.
- Concerns about false positives, leading to unnecessary worry or doctor visits.
- Some studies suggest its sensitivity and specificity may be overestimated and lower than advertised.
- Can be difficult to photograph certain areas of the body, and the front camera is not supported for quality reasons.
- Paid app with some users feeling it's expensive or doesn't offer a free trial as advertised.
- Some users reported discrepancies between AI assessment and professional evaluation.
Based on reviews from: The Medical Futurist, Apple App Store, Reddit, AJMC, Beauty Tech Derm, Google Play Store, Live Forever Club, Vice Magazine, Trustpilot
Last updated: 2026-08-11
Videos
News, demos, and interviews about SkinVision.
Videos load interactively. If none appear, search YouTube for SkinVision →
Press & Coverage
Frequently Asked Questions
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]